The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it worksSemaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individualsThe approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events